期刊文献+

白念珠菌锌簇转录因子编码基因表达与氟康唑耐药的关系 被引量:4

Relationship between the Expression of Genes Encoding Transcription Factors and Fluconazole Resistance in Candida albicans
下载PDF
导出
摘要 目的观察白念珠菌氟康唑耐药株和敏感株中锌簇转录因子编码基因UPC2,TAC1,MRR1和相关耐药基因CDR1,CDR2,MDR1,FLU1和ERG11的表达情况。方法抽提白念珠菌氟康唑耐药株组和敏感株组的总RNA,逆转录合成cDNA,采用实时定量PCR法检测相关基因的表达情况。结果白念珠菌耐药株组UPC2和CDR2基因的表达(7.22±4.21和2.45±1.37)均高于敏感株组(1.05±0.05和1.03±0.09),差异均有显著的统计学意义(P均<0.05);但是,TAC1(1.46±0.86和1.05±0.12)和MRR1基因的表达(0.72±0.58和1.09±0.11)差异均无统计学意义(P均>0.05)。结论 UPC2和CDR2基因的高表达与氟康唑耐药有关,锌簇转录因子在耐药中的作用有待于进一步研究。 Objective To explore the relationship between fluconazole resistance and expression of C. albicans genes encoding transcription factors UPC2 ,TAC1, MRR1 and drug resistance-related genes CDR1, CDR2, MDR1, FLU1, ERG11. Methods The total RNA was extracted from fluconazole-resistant and-susceptible C. albi- cans isolates and cDNA was synthesized. The expression of drug resistance-related genes was then detected by quantitative real-time PCR. Results Higher expression of UPC2 ( 7.22 ± 4.21 ) / CDR2 ( 2.45 ± 1.37 ) gene was observed in the flueonazole-resistant isolates than that in the fluconazole-suseeptible isolates. The difference was statistically significant ( all P 〈 0.05 ). However, the expression of TAC1 ( 0.46 ± 0.86 and 1.05 ± 0.12)/MRR1 (0.72 ± 0.58 and 1.09 ± 0.11 ) was no statistical difference ( all P 〉 0.05 ). Conclu- sion It is likely that the over-expression of UPC2 and CDR2 gene is relevant to fluconazole resistance in C. albicans. The function of Zinc cluster transcription fators in drug resitance needs to be further studied.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2013年第2期131-133,共3页 The Chinese Journal of Dermatovenereology
关键词 白念珠菌 耐药 锌簇转录因子 表达 氟康唑 Candida albicans resistance Zinc cluster transcription factors Expression Fluconazole
  • 相关文献

参考文献9

  • 1White TC,Marr KA,Bowden RA. Clinical,cellular,and molecular factors that contribute to antifungal drug resistance[J].Clinical Microbiology Reviews,1998,(02):382-402.
  • 2Michael AP,Pfaller MA,Shean DJ. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved StandardSecond edition[NCCLS document M27-A2,NCCLS][R].2002.
  • 3景伟芳,李春莉,王惠平.白念珠菌506株对氟康唑和伊曲康唑的体外药敏试验[J].中国皮肤性病学杂志,2011,25(1):30-32. 被引量:5
  • 4MacPherson S,Akache B,Weber S. Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes[J].Antimicrobial Agents and Chemotherapy,2005,(05):1745-1752.doi:10.1128/AAC.49.5.1745-1752.2005.
  • 5Hoot SJ,Oliver B J,White TC. Candida albicans UPC2 is transcriptionally induced in response to antifungal drugs and anaerobicity through Upc2p-dependent and-independent mechanisms[J].Microbiology,2008,(09):2748-2756.doi:10.1099/mic.0.2008/017475-0.
  • 6Dunkel N,Liu TT,Barker KS. A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate[J].Eukaryotic Cell,2008,(07):1180-1190.doi:10.1128/EC.00103-08.
  • 7Sadri Z,Sandra W,Perrine B. Genomewide Location Analysis of Candida albicans Upc2p,a Regulator of Sterol Metabolism and Azole Drug Resistance[J].Eukaryotic Cell,2008,(05):836-847.
  • 8Perea S,López-Ribot JL,Kirkpatrick WR. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans.strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients[J].Antimicrobial Agents and Chemotherapy,2001,(10):2676-2684.
  • 9Karababa M,Coste AT,Sanglard D. Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters[J].Antimicrobial Agents and Chemotherapy,2004,(04):3064-3079.

二级参考文献9

  • 1Wang H,Kong F,Sorrell TC,et al.Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing. BMC Microbiology . 2009
  • 2Tashiro M,Murakami H,Yoshizawa S,et al.Isolation rate and susceptibilities of Candida species from blood,vascular catheter,urine and stool. Kansenshogaku ZasshiKansenshogaku Za . 2010
  • 3Yamagishi Y,Terada M,Ohki E,et al.Antifungal susceptibility of Candida species isolated from patient with invasive fungal peritonitis and investigation on clinical breakpoints of itraconasole. Japanese Journal of Antibiotics . 2009
  • 4Sidrim J J,Maia DC,Brilhante RS,et al.Candida species isolated from the gastrointestinal tract of cockatiels(Nymphicus hollandicus):In vitro antifungal susceptibility profile and phospholipase activity. Veterinary Microbiology . 2010
  • 5Bougnoux ME,Kac G,Aegerter P,et al.Candidemia and candiduria in itically ill patients admitted to intensive care units in France:incidence, molecular diversity,management and outcome. Intensive Care Medicine . 2008
  • 6Basma R,Barada G,Ojaimi N,et al.Susceptibility ofCandida al-bicansto common and novel antifungal drugs,and relationship be-tween the mating type locus and resistance,in Lebanese hospital i-solates. Mycoses . 2009
  • 7Skrodeniene E,Dambrauskiene A,Vitkauskiene A.Suscep-tibility of yeasts to antifungal agents in Kaunas University ofMedicine Hospital. Medicina . 2006
  • 8徐永豪,李春阳,陈腊梅,胡勤峰.白念珠菌临床株氟康唑敏感性试验与ERG11基因突变检测[J].中华皮肤科杂志,2007,40(12):756-758. 被引量:4
  • 9吴颖,刘伟,万哲,李若瑜.氟康唑耐药的白念珠菌对唑类药物交叉耐药实验[J].中国皮肤性病学杂志,2009,23(3):148-149. 被引量:7

共引文献4

同被引文献34

  • 1王应斌,王宏,郭辉玉,赵永忠,罗深秋.白假丝酵母ERG11基因突变分析[J].第一军医大学学报,2005,25(11):1390-1393. 被引量:9
  • 2李丰霞,张宏.汉防己甲素对氟康唑抗白念珠菌活性的增效作用[J].中华皮肤科杂志,2006,39(8):454-456. 被引量:25
  • 3徐永豪,李春阳.耐唑类药白念珠菌ERG11基因点突变[J].中国真菌学杂志,2006,1(6):370-373. 被引量:8
  • 4赵辩.临床皮肤病学[M].南京:江苏科学技术出版社,2001.935.
  • 5Cateau E, Berjeaud JM, Rodier MH,et al. Fungal biofilm inhibition by a component naturally produced by Candida albicans yeasts growing as a biofilm [ J ]. Int J Antimicrob Agents, 2008 ,31 (2) : 166 - 170.
  • 6Finkel JS, Mitchell AP. Genetic control of Candida albicans biofilm de- velopment [ J ]. Nat Rev Microbiol, 2011,9 (2) : 109 - 118.
  • 7Ramage G, Vandewalle K, Wickes BL, et al. Characteristics of biofilm formation by Candida albicans [ J ]. Rev Iberoam Micol,2001,18 (4) : 163 - 170.
  • 8Hasan F, Xess I, Wang X, et al. Biofilm formation in clinical Candida isolates and its association with virulence [ J ]. Microbes Infect, 2009, 11(8 -9) : 753 -761.
  • 9Pierce CG, Uppuluri P, Tummala S, et al. A 96 well microtiter plate- based method for monitoring formation and antifungal susceptibility tes- ting of Candida albicans biofilms[J]. J Vis Exp, 2010, (44) : 2287.
  • 10Chandra J, Mukherjee PK, Leidich SD. Antifungal resistance of can- didal biofilrns formed on denture acrylic in vitro[ J]. J Dent Res ,2001 , 80(3 ) :903 -908.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部